Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tanja Fehm

Showing results (211-220 of 371) with videos related to

Pageof 38
Sort By:
BMJ Open|July 20, 2025
Psychosocial outcomes of risk-adapted prevention for prostate cancer predisposition: study protocol for a longitudinal observational mixed-methods studyMaike K Klett, Peter Albers, Jale Lakes, et al.
Plos One|October 31, 2017
Quantifying HER-2 expression on circulating tumor cells by ACCEPTLeonie Zeune, Guus van Dalum, Charles Decraene, et al.
Cancer Metastasis Reviews|November 7, 2012
Clinical application of circulating tumor cells in breast cancer: overview of the current interventional trialsFrançois-Clément Bidard, Tanja Fehm, Michail Ignatiadis, et al.
BMC Cancer|October 22, 2011
The PACOVAR-trial: a phase I/II study of pazopanib (GW786034) and cyclophosphamide in patients with platinum-resistant recurrent, pre-treated ovarian cancerMichael Eichbaum, Christine Mayer, Regina Eickhoff, et al.
Stem Cells International|December 12, 2017
Isolation and Molecular Characterization of Amniotic Fluid-Derived Mesenchymal Stem Cells Obtained from Caesarean SectionsLucas-Sebastian Spitzhorn, Md Shaifur Rahman, Laura Schwindt, et al.
BMC Cancer|November 14, 2019
Determination of the androgen receptor status of circulating tumour cells in metastatic breast cancer patientsNatalia Krawczyk, Melissa Neubacher, Franziska Meier-Stiegen, et al.
Breast Cancer Research and Treatment|March 5, 2014
Detection and clinical relevance of hematogenous tumor cell dissemination in patients with ductal carcinoma in situMalgorzata Banys, Markus Hahn, Ines Gruber, et al.
International Journal of Molecular Sciences|February 13, 2025
Pharmacological Inhibition of MDM2 Induces Apoptosis in p53-Mutated Triple-Negative Breast CancerJasmin Linh On, Sahel Ghaderi, Carina Rittmann, et al.
Breast Cancer Research and Treatment|July 14, 2018
The clinical relevance of serum vascular endothelial growth factor (VEGF) in correlation to circulating tumor cells and other serum biomarkers in patients with metastatic breast cancerMalgorzata Banys-Paluchowski, Isabell Witzel, Sabine Riethdorf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2011
Effect of luteinizing hormone-releasing hormone agonist on ovarian function after modern adjuvant breast cancer chemotherapy: the GBG 37 ZORO studyBernd Gerber, Gunter von Minckwitz, Heinrich Stehle, et al.
Pageof 38

Showing results (211-220 of 371) with videos related to

Sort By:
Pageof 38
BMJ Open|July 20, 2025
Psychosocial outcomes of risk-adapted prevention for prostate cancer predisposition: study protocol for a longitudinal observational mixed-methods studyMaike K Klett, Peter Albers, Jale Lakes, et al.
Plos One|October 31, 2017
Quantifying HER-2 expression on circulating tumor cells by ACCEPTLeonie Zeune, Guus van Dalum, Charles Decraene, et al.
Cancer Metastasis Reviews|November 7, 2012
Clinical application of circulating tumor cells in breast cancer: overview of the current interventional trialsFrançois-Clément Bidard, Tanja Fehm, Michail Ignatiadis, et al.
BMC Cancer|October 22, 2011
The PACOVAR-trial: a phase I/II study of pazopanib (GW786034) and cyclophosphamide in patients with platinum-resistant recurrent, pre-treated ovarian cancerMichael Eichbaum, Christine Mayer, Regina Eickhoff, et al.
Stem Cells International|December 12, 2017
Isolation and Molecular Characterization of Amniotic Fluid-Derived Mesenchymal Stem Cells Obtained from Caesarean SectionsLucas-Sebastian Spitzhorn, Md Shaifur Rahman, Laura Schwindt, et al.
BMC Cancer|November 14, 2019
Determination of the androgen receptor status of circulating tumour cells in metastatic breast cancer patientsNatalia Krawczyk, Melissa Neubacher, Franziska Meier-Stiegen, et al.
Breast Cancer Research and Treatment|March 5, 2014
Detection and clinical relevance of hematogenous tumor cell dissemination in patients with ductal carcinoma in situMalgorzata Banys, Markus Hahn, Ines Gruber, et al.
International Journal of Molecular Sciences|February 13, 2025
Pharmacological Inhibition of MDM2 Induces Apoptosis in p53-Mutated Triple-Negative Breast CancerJasmin Linh On, Sahel Ghaderi, Carina Rittmann, et al.
Breast Cancer Research and Treatment|July 14, 2018
The clinical relevance of serum vascular endothelial growth factor (VEGF) in correlation to circulating tumor cells and other serum biomarkers in patients with metastatic breast cancerMalgorzata Banys-Paluchowski, Isabell Witzel, Sabine Riethdorf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2011
Effect of luteinizing hormone-releasing hormone agonist on ovarian function after modern adjuvant breast cancer chemotherapy: the GBG 37 ZORO studyBernd Gerber, Gunter von Minckwitz, Heinrich Stehle, et al.
Pageof 38